T2 Biosystems, Inc. financial data

Symbol
TTOO on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
101 Hartwell Avenue, Lexington, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 45.7 % -47.3%
Quick Ratio 9.99 % -41.1%
Debt-to-equity -237 %
Return On Equity 212 % +61.5%
Return On Assets -155 % -10.8%
Operating Margin -630 % -59.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.5M shares -94.8%
Common Stock, Shares, Outstanding 17.4M shares -92.8%
Entity Public Float 17.1M USD -44.7%
Common Stock, Value, Issued 17K USD -93%
Weighted Average Number of Shares Outstanding, Basic 14.1M shares +1642%
Weighted Average Number of Shares Outstanding, Diluted 14.1M shares +1642%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 7.16M USD -45.7%
Research and Development Expense 12.9M USD -33.3%
Costs and Expenses 52.3M USD -19.9%
Operating Income (Loss) -45.1M USD +13.4%
Nonoperating Income (Expense) -3.16M USD -1262%
Net Income (Loss) Attributable to Parent -48.3M USD +6.81%
Earnings Per Share, Basic 117 USD/shares +91.8%
Earnings Per Share, Diluted 117 USD/shares +91.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.25M USD -73.6%
Marketable Securities, Current 0 USD
Accounts Receivable, after Allowance for Credit Loss, Current 1.3M USD -3.86%
Inventory, Net 5.17M USD +19.2%
Assets, Current 13M USD -45.6%
Property, Plant and Equipment, Net 1.52M USD -66.8%
Operating Lease, Right-of-Use Asset 6.66M USD -17.7%
Other Assets, Noncurrent 1K USD -98%
Assets 21.7M USD -41.5%
Accounts Payable, Current 1.69M USD -24.5%
Employee-related Liabilities, Current 2.59M USD -6.39%
Accrued Liabilities, Current 4.28M USD -58.9%
Contract with Customer, Liability, Current 237K USD -10.6%
Liabilities, Current 21.8M USD -67%
Contract with Customer, Liability, Noncurrent 74K USD +15.6%
Operating Lease, Liability, Noncurrent 5.75M USD -22.7%
Other Liabilities, Noncurrent 4.79M USD +12.6%
Liabilities 27.6M USD -62.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -11K USD -169%
Retained Earnings (Accumulated Deficit) -607M USD -8.64%
Stockholders' Equity Attributable to Parent -5.9M USD +83.8%
Liabilities and Equity 21.7M USD -41.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.7M USD +9.71%
Net Cash Provided by (Used in) Financing Activities 2.2M USD -81.4%
Net Cash Provided by (Used in) Investing Activities -120K USD -314%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 17.4M shares -92.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -9.48M USD -682%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.8M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 839K USD -16.8%
Deferred Tax Assets, Valuation Allowance 87.2M USD -0.69%
Deferred Tax Assets, Gross 89.4M USD -1.26%
Operating Lease, Liability 8.21M USD -14.1%
Payments to Acquire Property, Plant, and Equipment 120K USD +314%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -45.6M USD +28.1%
Lessee, Operating Lease, Liability, to be Paid 10.7M USD -18.4%
Property, Plant and Equipment, Gross 16.5M USD -14.2%
Operating Lease, Liability, Current 1.69M USD +14%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.33M USD -6.27%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.49M USD +3.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.46M USD -30%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.89M USD -18.8%
Deferred Tax Assets, Operating Loss Carryforwards 72.1M USD -0.29%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.95M USD +3.01%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 64K USD -75%
Deferred Tax Assets, Net of Valuation Allowance 2.12M USD -20.1%
Share-based Payment Arrangement, Expense 3.46M USD -32.1%
Interest Expense 5.71M USD -22.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%